Fujinaga, Shuichiro <br/><br/>
Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.  [electronic resource] 

 -  Pediatric nephrology (Berlin, Germany)  02 2019 
 - 353-357 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-198X 
<br/><br/><label>Standard No.: </label>10.1007/s00467-018-4145-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Administration, Oral<br/>Agammaglobulinemia--chemically induced<br/>Child<br/>Child, Preschool<br/>Cyclosporine--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Resistance--drug effects<br/>Drug Therapy, Combination--methods<br/>Female<br/>Follow-Up Studies<br/>Glucocorticoids--pharmacology<br/>Humans<br/>Immunosuppressive Agents--pharmacology<br/>Infant<br/>Japan<br/>Lymphocyte Depletion--adverse effects<br/>Male<br/>Nephrotic Syndrome--drug therapy<br/>Neutropenia--chemically induced<br/>Pulse Therapy, Drug<br/>Remission Induction--methods<br/>Retrospective Studies<br/>Rituximab--pharmacology<br/>Treatment Outcome